Discover the detailed record of transactions filed by Posard Matthew L., Director. Director active across 3 companies, notably Halozyme Therapeutics, INC.. Aggregated, 8 filings have been logged. Total volume traded: €162k. The latest transaction was filed on 26 May 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Posard Matthew L. is a Director at HALOZYME THERAPEUTICS, INC., DermTech, Inc., and Nautilus Biotechnology, Inc. He plays a key role in the governance of these companies, contributing to strategic decision-making and overseeing operations. His experience in the biopharmaceutical sector is a valuable asset.